Cronos Group/CRON

$2.37

-2.48%
-
1D1W1MYTD1YMAX

About Cronos Group

Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Lord Jones are hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions is a line-up of premium ice water hash infused pre-rolls. Its PEACE NATURALS offers Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.

Ticker

CRON

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Michael Gorenstein

Employees

626

Headquarters

Toronto, Canada

Cronos Group Metrics

BasicAdvanced
$899.18M
Market cap
-
P/E ratio
-$0.19
EPS
1.13
Beta
-
Dividend rate
$899.18M
1.12624
$2.92
$1.56
219.38K
22.544
21.808
-6.09%
-6.34%
-6.38%
10.231
0.817
0.835
0.96%
39.72%
23.14%

What the Analysts think about Cronos Group

Analyst Ratings

Majority rating from 7 analysts.
Hold

Price Targets

Average projection from 6 analysts.
13.5% upside
High $3.63
Low $2.06
$2.37
Current price
$2.69
Average price target

Cronos Group Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-187.02% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$23.9M
-3.63%
Net income
$-44.7M
2,693.75%
Profit margin
-187.02%
2,799.53%

Cronos Group Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 150%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.05
-$0.01
-
-$0.05
-
Expected
-$0.04
-$0.03
-$0.02
-$0.02
-$0.02
Surprise
17.65%
-67.73%
-
150%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Cronos Group stock?

Cronos Group (CRON) has a market cap of $899.18M as of April 22, 2024.

What is the P/E ratio for Cronos Group stock?

The price to earnings (P/E) ratio for Cronos Group (CRON) stock is 0 as of April 22, 2024.

Does Cronos Group stock pay dividends?

No, Cronos Group (CRON) stock does not pay dividends to its shareholders as of April 22, 2024.

When is the next Cronos Group dividend payment date?

Cronos Group (CRON) stock does not pay dividends to its shareholders.

What is the beta indicator for Cronos Group?

Cronos Group (CRON) has a beta rating of 1.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Cronos Group stock price target?

The target price for Cronos Group (CRON) stock is $2.69, which is 13.5% above the current price of $2.37. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Cronos Group stock

Buy or sell Cronos Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing